Questi cookie sono necessari per il funzionamento del sito e non possono essere disattivati nei nostri sistemi
Combining with DPP-4 inhibitors is generally not recommended, as both drug classes work on the incretin system Adding basal insulin for those with more significant hyperglycaemia, which can be used alongside GLP-1 medications (with careful monitoring for hypoglycaemia) Switching to insulin therapy entirely may be necessary for those with advanced beta cell failure For weight management , when GLP-1 medications don't produce adequate weight loss, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption, though weight loss is typically modest (2-3 kg on average) Naltrexone-bupropion (Mysimba), which works on appetite centres through different pathways
We review your medical history, conduct a physical examination, perform laboratory testing, and assess your lifestyle to gain a full understanding of your health
Monitoring may include weight, appetite, hydration, nutrition, kidney function when clinically relevant, blood glucose when needed, and digestive tolerability
